Clinical trial
A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy
NCT04704245 is registered in ClinicalTrials.gov with Hallym University Kangnam Sacred Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial on the Effectiveness of Epidermal Growth Factor-containing Ointment on the Treatment of Solar Lentigines as Adjuvant Therapy
- Lead sponsor
- Hallym University Kangnam Sacred Heart Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 20, 2017
- Completion date
- December 26, 2018
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
epidermal growth factor, hyperpigmentation, nd-yttrium aluminum garnet laser, post inflammatory hyperpigmentation